Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 3—March 2014


Infective Endocarditis in Northeastern Thailand

George WattComments to Author , Orathai Pachirat, Henry C. Baggett, Susan A. Maloney, Viraphong Lulitanond, Didier Raoult, Saithip Bhengsri, Somsak Thamthitiwat, Anucha Paupairoj, Michael Kosoy, Nongrak Ud-Ai, Wichuda Sukwicha, Toni Whistler, and Pierre-Edouard Fournier
Author affiliations: Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand (G. Watt, H.C. Baggett, S.A. Maloney, S. Bhengsri, S. Thamthitiwat, W. Sukwicha, T. Whistler); Khon Kaen University Faculty of Medicine, Khon Kaen, Thailand (O. Pachirat, V. Lulitanond, A. Paupairoj, N. Ud-Ai); Aix Marseille Université, Marseille, France (D. Raoult, P.-E. Fournier); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (H.C. Baggett, S.A. Maloney, T. Whistler); Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (M. Kosoy)

Cite This Article


Highlight and copy the desired format.

EID Watt G, Pachirat O, Baggett HC, Maloney SA, Lulitanond V, Raoult D, et al. Infective Endocarditis in Northeastern Thailand. Emerg Infect Dis. 2014;20(3):473-476.
AMA Watt G, Pachirat O, Baggett HC, et al. Infective Endocarditis in Northeastern Thailand. Emerging Infectious Diseases. 2014;20(3):473-476. doi:10.3201/eid2003.131059.
APA Watt, G., Pachirat, O., Baggett, H. C., Maloney, S. A., Lulitanond, V., Raoult, D....Fournier, P. (2014). Infective Endocarditis in Northeastern Thailand. Emerging Infectious Diseases, 20(3), 473-476.


Despite rigorous diagnostic testing, the cause of infective endocarditis was identified for just 60 (45.5%) of 132 patients admitted to hospitals in Khon Kaen, Thailand, during January 2010–July 2012. Most pathogens identified were Viridans streptococci and zoonotic bacteria species, as found in other resource-limited countries where underlying rheumatic heart disease is common.

Serologic testing of patients with blood culture–negative endocarditis has identified Coxiella burnetii, the causative agent of Q fever, and Bartonella spp. as noteworthy causes of infective endocarditits (IE) in resource–limited countries (14). Many cases of IE that were not diagnosed by standard blood culture were caused by zoonotic bacteria (5). Prospective, systematic descriptions of the etiology and characteristics of IE in Southeast Asia are lacking. We therefore collected detailed clinical, laboratory, and epidemiologic information for patients with confirmed IE in Khon Kaen, Thailand, and conducted specialized testing methods in addition to standard blood cultures to facilitate assessment for zoonotic and nonzoonotic bacteria as the cause of IE.

The Study

During January 25, 2010–July 19, 2012, patients were prospectively enrolled in this study at 2 tertiary care referral hospitals located on the campus of the medical school of Khon Kaen University. Srinagarind Hospital is a 777-bed general hospital, and the Queen Sirikit Heart Center of the Northeast is a 200-bed specialized cardiac center in which ≈10 heart valve replacement surgeries are performed each month. Patients with suspected IE are referred from much of northeastern Thailand, a region of ≈21 million persons.

Transthoracic echocardiography was performed for patients suspected of having IE; consenting patients >16 years of age who met modified Duke criteria for endocarditis were enrolled in this study. Underlying cardiac conditions were assessed by cardiologists on the basis of patients’ medical records, history, physical examination, and echocardiographic findings. At admission to a hospital, 3 separate blood samples for culture were obtained in <90 minutes. Blood was inoculated into aerobic medium (BD BACTEC Plus Aerobic/F Medium; Becton Dickinson, Franklin Lakes, NJ, USA), and cultures were processed by using an automated system (BD Bactec Fx series; Becton Dickinson). Pathogens were identified to species level whenever possible, but some blood culture isolates were defined only to the genus level (e.g., viridans group streptococci). One month after admission, a convalescent-phase serum specimen was obtained from each study patient and these patients were evaluated by a cardiologist.

Acute- and convalescent-phase serum specimens were tested for C. burnetii and Legionella pneumophila by indirect immunofluorescence assay (IFA) as described (5). Phase 1 IgG reciprocal titers >800 for C. burnetii and total antibody reciprocal titers ≥256 for L. pneumophila on either serum specimen were defined as positive (5). IFA IgG reciprocal titers of ≥800 to Bartonella quintana and Bartonella henselae were deemed positive. Specific antibodies to Brucella melitensis and Mycoplasma pneumoniae were detected with a commercial immunoenzymatic antibody test (Brucella antibody and Platellia M. pneumoniae IgM kits, respectively; Bio-Rad, Marnes-la-Coquette, France). Reciprocal titers ≥200 were considered positive. DNA was extracted from surgically excised heart valves by using the QIAamp DNA FFPE Tissue Kit (QIAGEN, Courtaboeuf, France) as described by the manufacturer. Previously described broad spectrum PCR primers and amplification and sequencing conditions (4) were used to detect all bacteria (16S rRNA); all fungi (18S rRNA); Staphylococcus aureus, mitis and gallolyticus group streptococci, Enterococcus faecalis and E. faecium, Mycoplasma hominis, C. burnetii, Bartonella spp., and Tropheryma whipplei.

Table 1 describes characteristics of the 132 enrolled patients: the median age was 47 years (range 16–85) and 68.9% were male. Most of the study patients lived in rural areas, most had a history of animal contact, and most were farmers of rice or vegetables. All study patients had definite IE as determined by using modified Duke criteria. Patients had high fever and were severely ill at admission; more than half had congestive heart failure (Table 1). Underlying cardiac pathologic changes were identified in 96 (72.7%) study patients (Table 1); rheumatic heart disease (RHD) was the most common condition, as has been found in other resource-limited countries (1,2,6,7). RHD was identified in 37 (28.0%) of the 132 patients overall; the 37 represented 38.5% of the 96 patients with identified underlying cardiac pathologic changes. IE was detected on prosthetic heart valves in 12 (9.9%) of the study patients, including 2 patients whose blood cultures grew coagulase-negative staphylococci.

Of the 132 study patients, 100 (75.8%) underwent surgery. Such management reflects current international guidelines for complicated IE, which emphasize identifying high-risk patients, transferring them to a specialized medical–surgical center, and performing early valvular surgery (8). Within 1 month, 11 (8.3%) of the 132 patients died and 6 were still hospitalized; 5 died after discharge. Four additional patients are known to have died after leaving the study, but we did not systematically assess survival beyond the 1-month follow-up examination. The case-fatality proportion calculated on the basis of known deaths was 11.4%, but the possibility of additional fatalities cannot be excluded. The mortality rate was 18.8% for patients who did not undergo surgery and 9.0% for those who did.

A pathogen was identified for 60 (45.5%) cases (Table 2). The etiologic agent was identified for 7 (21.9%) of 32 nonsurgical cases, 5 by blood culture and 2 by IFA, compared with 53 (53.0%) of the 100 study patients who underwent surgery (Fisher exact test, p = 0.02). Among patients who underwent surgery, diagnosis was made by PCR of heart valve tissue for 29, by blood culture for 11, and by >1 method for the remaining 13; no discrepancies between results from different diagnostic modalities were found. Many (80.3%) patients had been referred from other hospitals for management of IE and were already being treated for that illness. We confirmed that 77 (58.3%) patients had received antibacterial drugs during the week before admission. We suppose that the low diagnostic yield was associated with antibacterial drug use, but more detailed information is needed to determine the accuracy of this supposition.

Among the 60 cases of IE for which a causative pathogen was identified, 15 (25.0%) were attributed to zoonotic bacteria (Table 2): C. burnetti (5 cases), B. henselae (4 cases), Streptococcus suis (4 cases), Erysipelothrix rhusiopathiae (1 case), and Campylobacter fetus (1 case). B. quintana causes ≈75% of Bartonella IE cases worldwide (9) but was not found in this study. Verification that C. burnetti (10), Bartonella spp. (11), E. rhusiopathiae, and C. fetus cause IE in Thailand highlight the noteworthiness of emerging zoonotic pathogens in this region. The identification of Q fever IE stimulated efforts by public health authorities of Thailand to characterize Q fever prevalence and transmission nationwide.

Streptococci generally cause the majority of infections of native heart valves (12), and 90.1% of patients in this study had native valve involvement. Viridans streptococci, including S. suis, accounted for 43.3% of cases of known etiology (Table 2) and included 3 species of streptococci not previously reported to cause IE in Thailand (S. gallolyticus, S. difficilis, and S. sinensis). In Thailand, as elsewhere, health care–associated IE and IE among intravenous drug users is often caused by S. aureus (13,14). None of the patients in this study were known to be intravenous drug users, and few had health care–associated infections; 5 (8.3%) of 60 cases were caused by S. aureus.


Zoonotic bacteria were detected by specialized testing of 11.4% of IE patients in northeastern Thailand, but an etiology could not be determined for more than half (54.5%) of the patients. Infections with viridans streptococci predominated among cases of known etiology, and RHD was the most common underlying pathologic change. To increase diagnostic yield, we recommend intensification of efforts to obtain blood cultures in the absence of antimicrobial drugs and increase of laboratory capacity to test for zoonotic bacteria (15).

Dr Watt is a tropical medicine consultant at the International Emerging Infectious Diseases program in the Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration. He is principal investigator of a project that seeks to define the causes and risk factors of infective endocarditis in Thailand. His main research interests are zoonotic infections and interactions between HIV-1 and tropical diseases of public health importance.


This work was supported by the Global Disease Detection Program and the Division of Vector Borne Infectious Diseases at the Centers for Disease Control and Prevention, USA and the Méditerranée Infection Foundation, Marseille, France.


  1. Balakrishnan N, Menon T, Fournier PE, Raoult D. Bartonella quintana and Coxiella burnetii as causes of endocarditis, India. Emerg Infect Dis. 2008;14:11689. DOIPubMed
  2. Benslimani A, Fenollar F, Lepidi H, Raoult D. Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis. 2005;11:21624. DOIPubMed
  3. Lamas CC, Ramos RG, Lopes GQ, Santos MS, Golebiovski WF, Weksler C, Bartonella and Coxiella infective endocarditis in Brazil: molecular evidence from excised valves from a cardiac surgery referral center in Rio de Janeiro, Brazil, 1998 to 2009. Int J Infect Dis. 2013;17:e656. DOIPubMed
  4. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta J-P, Arzouni J-P, Comprehensive diagnostic strategy for blood culture–negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51:13140. DOIPubMed
  5. Houpikian P, Raoult D. Blood culture–negative endocarditis in a reference center. Etiologic diagnosis of 348 cases. Medicine. 2005;84:16273. DOIPubMed
  6. Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol. 2008;102:124751. DOIPubMed
  7. Nunes MCP, Gelape CL, Ferrari TAB. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period. Int J Infect Dis. 2010;14:e3948. DOIPubMed
  8. Thuny F, Grisoli D, Collart F, Habit G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379:96575. DOIPubMed
  9. Brouqui P, Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol. 2006;47:113. DOIPubMed
  10. Pachirat O, Fournier PE, Pussadhamma B, Taksinachanekij S, Lulitanond V, Baggett HC, The first reported cases of Q fever endocarditis in Thailand. Infectious Disease Reports. 2012;4:178. DOI
  11. Pachirat O, Kosoy M, Bai Y, Prathai S, Puapairoj A, Zeidner N, The first reported case of Bartonella endocarditis in Thailand. Infectious Disease Reports. 2011;3:445. DOI
  12. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolger AF, Levison ME, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394434 and. DOIPubMed
  13. Nickerson EK, Hongsuwan M, Limmathurotsakul D, Wuthiekanun V, Shah KR, Srisomang P, Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS ONE. 2009;4:e4308. DOIPubMed
  14. Srifuengfung S, Yungyuen T, Komolpis P. Bacterial isolation and antimicrobial susceptibilities in patients with infective endocarditis. Southeast Asian J Trop Med Public Health. 2004;35:897901 .PubMed
  15. Lamas C. Diagnostic strategy for blood culture–negative endocarditis. Clin Infect Dis. 2010;51:1412. DOIPubMed


Cite This Article

DOI: 10.3201/eid2003.131059

Table of Contents – Volume 20, Number 3—March 2014


Please use the form below to submit correspondence to the authors or contact them at the following address:

George Watt, DTM&H; IEIP, DDC 7 Building, 3rd Floor; Ministry of Public Health, Soi 4, Nonthaburi 11000, Thailand; emailGeorge Watt, DTM&H; IEIP, DDC 7 Building, 3rd Floor; Ministry of Public Health, Soi 4, Nonthaburi 11000, Thailand; email

character(s) remaining.

Comment submitted successfully, thank you for your feedback.